D-0145-2017 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-0145-2017 was initiated by Sandoz Inc on Oct 19, 2016 and is designated Class III. Reason for recall: Labeling: Missing Label The recall status is terminated (terminated Jul 27, 2017). Affected quantity: 139,430 vials.

Recall details

Product Type
Drugs
Report Date
Nov 30, 2016
Initiation Date
Oct 19, 2016
Termination Date
Jul 27, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
139,430 vials

Product description

Ceftriaxone for Injection, USP, 1 gram, 10 Single use Vials, Rx only, For IM or I.V. Use, Manufactured by: Sandoz GMbH for Hospira Worldwide, Inc., Lake Forest, Il 60045, USA, Made in Austria, NDC 0409-7332-01

Reason for recall

Labeling: Missing Label

Distribution pattern

WI

Code information

Sandoz - Lot GJ7151(Pfizer- Lot 670028M); Exp. 07/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0145-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0145-2017. Report a data issue: hello@regdatalab.com.